C08C Selective calcium channel blockers with mainly vascular effects
ATC class of level 3 – pharmacological subgroup
This page lists the patient medication information or the product monograph for 71 drugs in this drug class and its subclasses.
- 71 prescription (Rx)
Place in the ATC system
- C Cardiovascular system drugs 1,385 drugs
- C08 Calcium channel blockers 123 drugs
- C08C Selective calcium channel blockers with mainly vascular effects 71 drugs
- C08 Calcium channel blockers 123 drugs
Active ingredients of the class
- Acetylsalicylic acid 1 drug
- Amlodipine (amlodipine besylate) 46 drugs
- Amlodipine besylate 1 drug
- Clevidipine 1 drug
- Felodipine 4 drugs
- Nifedipine 17 drugs
- Nimodipine 2 drugs
Drugs in the class and its subclasses
Other classes of the same level
Other names of the drug class
- Czech: C08C Selektivní blokátory kalciových kanálů s přev. vaskulár. účinkem
- English (United Kingdom): C08C Selective calcium channel blockers with mainly vascular effects
- French: C08C inhibiteurs calciques sélectifs à effets vasculaires prédominants
- German: C08C Selektive Calciumkanalblocker mit vorwiegender Gefässwirkung
- Spanish: C08C Bloq. canales calcio selectivos efecto vascular
- German (Austria): C08C SELEKTIVE CALCIUMKANALBLOCKER MIT VORWIEGENDER GEFÄSSWIRKUNG
- Italian: C08C CALCIOANTAGONISTI SELETTIVI CON PREVALENTE EFFETTO VASCOLARE
- Polish: C08C Selektywne blokery kanału wapniowego z rozpowszechnieniem naczyniowym. efekt
- Turkish: C08C BAŞLICA VASKÜLER ETKİLERİ OLAN SEÇİCİ KALSİYUM KANAL BLOKERLERİ
- Portuguese (Brazil): C08C BLOQUEADORES SELECTIVOS DOS CANAIS DO CÁLCIO, COM ACÇÃO PREDOMINANTEMENTE VASCULAR
- Slovak: C08C Selektívne blokátory kalciového kanála s prevažne vaskulárnym účinkom
- German (Switzerland): C08C Selektive Calciumkanalblocker mit vorwiegender Gefässwirkung
- French (Switzerland): C08C Inhibiteurs calciques sélectifs à effets vasculaires prédominants
- Italian (Switzerland): C08C Calcioantagonisti selettivi con prevalente effetto vascolare
- Dutch: C08C Selectieve calciumantagonisten met overwegend vasculaire werking
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class C08C
Ask your doctor or pharmacist for advice.